Check out our other projects here 

 

UoM Spinout Complement Therapeutics Announces First Patient Dosed with CTx001

The Opti-GAIN study is being advanced alongside Pre-GAIN, the Company’s ongoing natural history study in GA currently enrolling in both the United States and the United Kingdom. Together, these studies are intended to support patient selection and the evaluation of novel structural and functional endpoints, including ellipsoid zone (EZ) and focal Optical Coherence Tomography (OCT)-based microperimetry. Opti-GAIN is among the first studies to prospectively evaluate focal OCT-based microperimetry, an approach that has the potential to advance how the treatment effect is assessed in Geographic Atrophy.

Britest Celebrates 25 Years of Innovation in Sustainable Process Design

Britest, a pioneering company from The University of Manchester, is celebrating its 25th anniversary, marking a quarter century of supporting industry to design safer, more efficient and more sustainable manufacturing processes.

University of Manchester spinout Spotlight Pathology announces £1.4m investment

Spotlight Pathology, a health tech company spun out from The University of Manchester, has announced that it has secured £1.4 million in funding to advance its AI-powered technology designed to support faster and more consistent diagnosis of blood cancers.

Cytotrait secures £3M seed funding to address global food security and sustainable agriculture

Cytotrait, a biotechnology spinout from The University of Manchester commercialised with support from the University of Manchester Innovation Factory, focused on the development of novel traits for food and agriculture, today announced the close of its £3M seed funding round.